AstraZeneca buys US vaccine company in $1.1bn deal

Britain ’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy businessAstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid-19 pandemic.Britain ’s biggest drugmaker has agreed to take over the Seattle-based company Icosavax, which is developing a potential vaccine for two common respiratory diseases.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: AstraZeneca Pharmaceuticals industry Business Vaccines and immunisation Society Health Mergers and acquisitions Medical research Science Source Type: news